Nucleic acid therapeutics: Past, present, and future
Molecular Therapy Nucleic Acids · 2025-03 · 36 (1) · 102440
DOI: 10.1016/j.omtn.2024.102440 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Therapy Nucleic Acids, 2025-03. Verfasst von Sajid Naeem und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality, Guangdong Provincial Department of Science and Technology.
Abstract (Originalsprache)
Nucleic acid therapeutics have become increasingly recognized in recent years for their capability to target both coding and non-coding sequences. Several types of nucleic acid modalities, including siRNA, mRNA, aptamer, along with antisense oligo, have been approved by regulatory bodies for therapeutic use. The field of nucleic acid therapeutics has been brought to the forefront by the rapid development of vaccines against COVID-19, followed by a number of approvals for clinical use including much anticipated CRISPR-Cas9. However, obstacles such as the difficulty of achieving efficient and targeted delivery to diseased sites remain. This review provides an overview of nucleic acid therapeutics and highlights substantial advancements, including critical engineering, conjugation, and delivery strategies, that are paving the way for their growing role in modern medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China.
- College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China.
- School of Biomedical Engineering, Harbin Institute of Technology (Shenzhen), Shenzhen 518055, Guangdong, China.
- Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Förderung
- National Natural Science Foundation of China
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Guangdong Provincial Department of Science and Technology
- National Key Research and Development Program of China
- China Postdoctoral Science Foundation
Zitieren
APA
Naeem, S., Zhang, J., Zhang, Y., & Wang, Y. (2025). Nucleic acid therapeutics: Past, present, and future. Molecular Therapy Nucleic Acids, 36(1), 102440. https://doi.org/10.1016/j.omtn.2024.102440
Vancouver
Naeem S, Zhang J, Zhang Y, Wang Y. Nucleic acid therapeutics: Past, present, and future. Molecular Therapy Nucleic Acids. 2025;36(1):102440. doi:10.1016/j.omtn.2024.102440
BibTeX
@article{Naeem2025,
author = {Naeem, Sajid and Zhang, Ju and Zhang, Yang and Wang, Yu},
title = {Nucleic acid therapeutics: Past, present, and future},
journal = {Molecular Therapy Nucleic Acids},
year = {2025},
volume = {36},
number = {1},
pages = {102440},
doi = {10.1016/j.omtn.2024.102440}
}
EUVIMED